Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21355097 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
Conditions: Cutaneous T Cell Lymphoma;   Peripheral T Cell Lymphoma
Intervention: Drug: Romidepsin

Study has passed its completion date and status has not been verified in more than two years.